![]() |
|
|
Department of Nutrition, The Pennsylvania State University, University Park, PA 16802 and * Department of Neuroscience and Anatomy, Milton S. Hershey Medical Center, The Pennsylvania State University College of Medicine, Hershey, PA 17033
Iron deficiency in young rats leads to a decrease in brain iron and ferritin concentrations, an increase in transferrin (Tf ) concentration, and an increased rate of uptake of iron from the plasma pool. We conducted two experiments to determine whether brain iron, Tf and ferritin respond quickly to iron repletion and to determine whether brain regions respond heterogeneously. Weanling male Sprague-Dawley rats were fed an iron-deficient diet (<5 mg/kg Fe) for 2 wk followed by an iron-adequate diet (REPL group, 35 mg/kg Fe in Experiment 1 and 15 mg/kg Fe in Experiment 2) for 2 or 4 wks, respectively. Age-matched iron-deficient (ID) and control rats composed the other two groups. Fourteen days of repletion with 35 mg/kg Fe dietary treatment were adequate to normalize hematology, brain microsomal and cytosolic Fe and brain ferritin (Experiment 1). Brain transferrin concentrations in REPL rats, however, were significantly above the levels of controls. Regional brain iron decreased heterogeneously due to dietary iron deficiency (Experiment 2), with some regions having a propensity to keep iron (e.g., substantia nigra, pons, and thalamus) and others losing significant amounts of iron (cortex and hippocampus). Ferritin and Tf concentrations also varied significantly across brain regions in ID and control rats. The hippocampus had the most dramatic Tf response to iron deficiency with elevations of approximately 100%, whereas other regions, except striatum, were unaffected. The brain of developing rats thus distributes iron and iron regulatory proteins differently from the brain of adult rats and is quite avid in its reacquisition of iron during iron therapy.
KEY WORDS: iron deficiency anemia · transferrin · ferritin · brain · ratsIron deficiency and anemia are major nutritional concerns throughout the world (Baynes and Bothwell 1990
). Iron deficiency has been associated with hematological changes (red blood cell deformation), stunted growth, altered thermoregulatory function and decreased cognitive function (Ashkenazi et al. 1982
, Brigham and Beard 1996
, Lozoff and Brittenham 1986
). Iron is essential for proper central nervous system metabolism through its role in the synthesis of neurotransmitters, myelin formation and brain growth (reviewed by Beard et al. 1993
). In iron-deficient rats, there is a significant decrease in brain iron, increase in brain transferrin and a slight decrease in brain ferritin concentration (Chen et al. 1995b
). It is unclear whether these changes in iron metabolism are due to altered acquisition or slow turnover rate of brain iron (Dallman and Spirito 1977
). By examining changes in brain iron and iron regulatory proteins due to iron repletion in rats, we sought to gain a clearer sense of how the brain regulates changes in iron concentration due to iron deficiency.
Iron is heterogeneously distributed in the brain of adults, with the highest concentration being in the basal ganglia, substantia nigra and deep cerebellar nuclei (Hill 1988
). It has recently been shown that some of the areas of the brain that are iron rich in adult rat brains are not iron rich for the first 60 d of life (Benkovic and Connor 1993
). Because the concentration of iron is highest in the brain at birth, decreases through weaning and then begins to increase during critical periods of development, e.g., myelination (Roskams and Connor 1994
), it is of great interest to examine the regional responses of the brain to dietary iron deficiency during growth. Developmental iron deficiency clearly alters the functioning of the brain in rats with functional sequelae (Felt and Lozoff 1996
).
Iron is stored in the brain primarily as ferritin, whereas transferrin is responsible for transporting iron in cerebral spinal fluid and in plasma (Connor et al. 1992
, Octave et al. 1983
). Both ferritin and transferrin levels are highest at birth in newborn rats and decline thereafter (Roskams and Connor 1994
). Overall, very little is known about the regional response of transferrin and ferritin to iron deficiency and iron repletion during development.
The reversibility of the observed alterations in brain iron metabolism due to iron deficiency has yet to be elucidated (Dallman and Spirito 1977
). Although young iron-deficient rats respond rapidly to iron repletion therapy with respect to hematology and storage of non-heme liver iron, it is not clear if the brain transferrin and ferritin concentrations respond to iron repletion in a rapid fashion. Further, it is unclear if the brain responds heterogeneously with respect to iron repletion, i.e., does an supposedly iron-rich region such as the substantia nigra acquire the same amount of iron, transferrin and ferritin as regions, such as the cortex, that have a lower concentration of iron?
|
Table 1. Hematological variables and liver non-heme iron concentration in iron-deficient rats (ID), control rats (CN) and rats fed iron-deficient diet followed by an iron-adequate diet (REPL) in Experiment 11 |
Thus, this study consisted of two experiments in post-weaning rats; the first experiment addressed the effect of iron repletion on brain iron, transferrin and ferritin levels, and the second experiment expanded on this by examining changes in different brain regions due to systemic iron deficiency and then repletion. Our hypothesis was that the brain would respond to iron depletion and to repletion in a heterogeneous fashion. This hypothesis was tested at only one developmental stage, but clearly, other developmental periods require careful examination.
20°C prior to analysis for iron and total iron-binding capacity (TIBC).
Non-heme iron and plasma iron and total iron-binding capacity.
Liver and spleen non-heme iron were measured by acid hydrolysis using the standard spectrophotometric technique as described in Cook (1980)
70°C. The brains were homogenized 1:5 (wt/v) in ice-cold buffer H, which contained 20 mmol/L HEPES, 250 mmol/L sucrose, 1 mmol/L EDTA, 100 mmol/L leupeptin and 100 mmol/L phenylmethylsulphonyl fluoride (PMSF ) at pH 7.2 using an Ultra-Turrax homogenizer (Tekmar, Cincinnati, OH) at high output for 30 s. All steps were performed at 4°C. The homogenates were centrifuged at 1000 × g for 10 min, and the crude supernatant was collected and centrifuged at 21,000 × g for 20 min. The resulting supernatant was subjected to centrifugation at 100,000 × g for 60 min, yielding a microsomal pellet and a cytosolic supernatant. Aliquots of these fractions were used for the analysis of protein, ferritin and transferrin concentrations; a 30-µL aliquot from each fraction was diluted 1:50 with 3.12 mmol/L ultra-pure nitric acid and analyzed in triplicate for iron by graphite furnace atomic absorption spectrophotometry (model 5100 AA, Perkin-Elmer, Norwalk, CT) (adapted from Chen et al. 1995b
Brain histochemistry. Some rats from each group in Experiment 2 were also treated at death for brain histochemistry analysis. Rats were perfused with 10% neutral buffered formalin. The brains were removed, immersed in the fixative (10% neutral buffered formalin) overnight and then cryoprotected by floating in sucrose (10, 20 and 30%) sequentially. The brains were then stored in 30% glycol until they were sectioned on a freezing microtome (30-µm sections). Cellular iron distribution was determined on individual brain sections using a modified Perls' reaction (Dickinson and Connor 1994
diaminobenzidine to enhance the visualization of the cellular iron) has become standard practice for microscopic analysis of rodent brains (Roskams and Connor 1994
Statistical analyses. Potential outliers in the data were identified as extreme values in boxplots within the boxplot program in Minitab (Minitab Corp., State College, PA). Outlier data were identified and excluded from the analyses. This consisted of one or two data points each for iron, transferrin and ferritin. Simple one-way ANOVA was used to test for differences in means in Experiment 1. Analysis of variance with two main effects (brain region and dietary treatment) and an interaction term was used for the analysis in Experiment 2 and was conducted after log transformation of data in some cases. The Type III sums of squares was used to calculate F ratios. Dunnett's procedure was performed to determine whether treatments differed from controls (Steel and Torrie 1980
0.05. All analyses of variance were conducted with either Minitab software or the Statistical Analysis System (SAS Institute, Cary, NC) using the Pennsylvania State University IBM mainframe computer. The General Linear Models (GLM) approach was used. Regression analysis was performed to evaluate the relationship between brain region iron and hematologic iron status variables and non-heme liver iron. Data are reported as means ± SEM.
|
Table 2. Hematological variables and liver non-heme iron concentrations in iron deficient rats (ID), control rats (CN) and rats fed iron-deficient diet followed by an iron-adequate diet (REPL) in Experiment 21 |
|
Table 3. Growth and food efficiency in iron-deficient rats (ID), control rats (CN) and rats fed iron-deficient diet followed by an iron-adequate diet (REPL) in Experiment 2 over the last 4 wk of the protocol1 |
, Roskams and Connor 1994
). Hippocampus and cortex were the only two regions with significantly lower levels of iron in response to dietary ID (P < 0.05). When regional iron concentration in ID rats was expressed as a percentage of that in CN rats, the hippocampus and cortex were 57 and 64% of CN (P < 0.05) compared with ~80 to >100% of CN in all other regions.
Fig. 3.
Regional brain iron concentrations of iron-deficient (ID, n = 8), control (CN, n = 8) and iron-replenished rats (REPL, n = 16) measured in tissue homogenates (Experiment 2). Values are means ± SEM. Brain regions examined were cerebral cortex (cortex), deep cerebellar nuclei (DCBN), hippocampus (Hippo), pons, striatum, substantia nigra (SNigra), superficial cerebellum (SupCB) and thalamus (Thal). The distribution of iron was significantly different across regions (P < 0.01) within all three treatment groups. Iron deficiency had an overall main effect of lowering brain iron (P < 0.01). Means with different letters within a brain region differed significantly (P < 0.05). Control rats had significantly higher concentrations (P < 0.01) of iron in hippocampus than any other brain region as noted by an asterisk.
[View Larger Version of this Image (27K GIF file)]
Fig. 4.
Regional brain transferrin concentrations for iron-deficient (ID, n = 8), control (CN, n = 8), and iron-replenished rats (REPL, n = 16) measured in tissue homogenates. Brain regions examined were cerebral cortex (cortex), deep cerebellar nuclei (DCBN), hippocampus (Hippo), pons, striatum, substantia nigra (SNigra), superficial cerebellum (SupCB) and thalamus (Thal). The distribution of transferrin was significantly different across regions (P < 0.01) in the ID and REPL treatment groups and approached significance in the CN treatment group (P = 0.067). Means with different letters within a brain region differed significantly (P < 0.05). Iron deficiency had an overall main effect of increasing brain transferrin (P < 0.05), though hippocampus was the only region in which transferrin was significantly higher (P < 0.01) than in any other brain region, as noted by an asterisk.
[View Larger Version of this Image (27K GIF file)]
Fig. 5.
Regional brain ferritin concentrations for iron-deficient (ID, n = 8), control (CN, n = 8) and iron-replenished rats (IR, n = 16) determined in cytosolic fractions. Brain regions examined were cerebral cortex (cortex), deep cerebellar nuclei (DCBN), hippocampus (Hippo), pons, striatum, substantia nigra (SNigra), superficial cerebellum (SupCB) and thalamus (Thal). The distribution of ferritin was significantly different across regions (P < 0.01) in all three treatment groups. Iron deficiency had an overall main effect of decreasing brain ferritin concentration (P < 0.05).
[View Larger Version of this Image (32K GIF file)]
Fig. 6.
Scatter plots of blood hemoglobin concentration (Hb) vs. brain iron concentration in cerebral cortex (top panel) and in substantia nigra (bottom panel) in iron-deficient anemic, control and iron-replenished rats. The univariate correlation was significant (r = 0.883, P < 0.001) in cortex but not in the substantia nigra.
[View Larger Version of this Image (16K GIF file)]
These experiments demonstrate several new aspects regarding iron metabolism in the brain of post-weaning rats. 1) Two weeks of iron repletion are adequate for correcting the overall iron concentration of the brain after a short duration of iron deficiency. However, adaptive processes such as changes in transferrin levels are still ongoing at this time (Experiment 1). 2) Iron and iron regulatory proteins, transferrin and ferritin, are distributed heterogeneously in the young rat brain and respond to iron repletion in a heterogeneous fashion (Experiment 2). In other words, brain regions have the apparent capacity to regulate their iron concentrations in response to local needs when faced with an alteration in systemic iron delivery. Although the mechanisms of this local regulation are not yet clear, this is the first demonstration that not all regions of the brain are altered equally by systemic iron deficiency.
). Repletion studies also demonstrate that the rat brain is fully capable of regaining iron in a rapid fashion, despite early observations that brain turnover (or more exactly, brain iron loss from the body) was a very slow process (Dallman and Spirito 1977
). Others have shown an increase in iron uptake into the rat brain during iron deficiency, with transcytosis of iron and transferrin across the blood brain barrier (Crowe and Morgan 1992
). The brain obtains iron via regulation of the transferrin receptor on the surface of endothelial cells on the brain microvasculature (Kalaria et al. 1992
). The increase in uptake of iron observed in iron deficiency is not reflective of overall changes in blood brain barrier permeability and is highly selective for iron and transferrin. Although speculative at this time, it is reasonable to assume that upregulation of transferrin receptors is partially responsible for this alteration in uptake, because they also have a heterogeneous distribution (Hill et al. 1985
, J. R. Connor, unpublished observation).
, Focht et al. 1997
, Hill 1988
, Roskams and Connor 1994
). In a recent quantitative study using brains of 10-wk-old Fisher 344 rats, the striatum, hippocampus, thalamus and frontal cortex had equivalent iron concentrations of approximately 820 nmol/g, followed by brain stem, medial cortex, pons and cerebellum with 625-715 nmol/g (Focht et al. 1997
). This is about double the amount measured here, where iron intake was much more highly regulated. Although there is a rough similarity in the distribution of iron, the absolute differences are more pronounced. In the same study, older (24-mo-old) rats had further iron accumulations to at least 890 nmol/g. Systematic evaluations of strain differences in brain iron distribution in rats have not been conducted. The substantia nigra, an iron-rich region in the adult rat brain as measured by histochemical methods (Hill 1988
), is not particularly high in iron concentration in young rats. This region did, however, exhibit a dramatic increase in iron concentration during iron repletion, suggesting that iron was somehow "targeted" to go to the substantia nigra. It is interesting to recall that substantia nigra, globus pallidus and caudate putamen accumulate iron in elderly humans, particularly those with Alzheimer's disease and Parkinson's disease (Connor 1992
, Good et al. 1992
, Loeffler et al. 1995
). Direct determinations of the regional responses of the transferrin receptor in future studies will test the possibility that it is upregulation of the transferrin receptor that is responsible for this targeted uptake of iron.
, Chen et al. 1995a
, Youdim et al. 1989
). The substantia nigra is rich in both iron and dopaminergic neurons (Bjorklund and Lindvall 1984
, Hill 1988
). The nigro-striatal dopaminergic pathway in the striatum has been found to be sensitive to iron deficiency with both decreases in dopamine D2 receptors and increases in extracellular dopamine observed (Ashkenazi et al. 1982
, Chen et al. 1995a
, Youdim et al. 1989
). Recent studies from our laboratory demonstrate that extracellular dopamine concentrations in the striatum return to normal within this same time frame for restoration of ventral mid-brain iron content (Nelson, C., Erikson, K. and Beard, J. L., unpublished observations). In addition, radioligand binding studies demonstrate alterations in dopamine transporters in striatal pathways in iron deficiency (Morse, A., Jones, B., and Beard, J. L., unpublished observations).
). Cytological examination in the current study revealed "immature" appearing oligodendrocytes as a result of iron deficiency, which do not immediately revert to normal appearance within several weeks of iron therapy. These cells actively express transferrin receptor during development; when their function is compromised, the receptor expression drops dramatically (Roskams and Connor 1992
). In addition, transferrin mRNA production and oligodendrocyte maturation are tightly coupled processes, suggesting that iron availability to these cells has a direct influence on their functioning (Bartlett et al. 1991).
). Current studies with more refined antibodies for specific chains of ferritin will provide an answer to whether specific H:L ratio changes occur in response to development and iron status.
). One earlier study noted that caudate putamen iron concentration could be restored within several months of iron therapy in the post-weaning rats (Ben-Shachar et al. 1986
). In contrast, pre-weaning or lactational exposure to low iron leads to irreversible changes in brain iron even after repletion for long periods of time (Dallman and Spirito 1977
, Felt and Lozoff 1996
, Youdim et al. 1989
). Because peak myelination occurs around postnatal d 10 in rats, it is reasonable to assume this is a critical period, during which oligodendrocyte requirements for iron are quite high. Our current protocol did not address this question but the observed changes in oligodendrocyte appearance in iron deficiency after postnatal d 21 demonstrate a continued sensitivity to iron status well beyond the early and peak portions of the myelination period.
, Crowe and Morgan 1992
). The regional variation suggests, however, the possibility that transferrin plays a role in some sort of distribution system that likely requires the expression of transferrin and transferrin receptor.
will help us to identify the critical periods of development during which "reversible" damage becomes "irreversible" damage.
Manuscript received 28 January 1997. Initial reviews completed 18 March 1997. Revision accepted 10 June 1997.
This article has been cited by other articles:
![]() |
E. L. Unger, J. A. Wiesinger, L. Hao, and J. L. Beard Dopamine D2 Receptor Expression Is Altered by Changes in Cellular Iron Levels in PC12 Cells and Rat Brain Tissue J. Nutr., December 1, 2008; 138(12): 2487 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadziahmetovic, T. Dentchev, Y. Song, N. Haddad, X. He, P. Hahn, D. Pratico, R. Wen, Z. L. Harris, J. D. Lambris, et al. Ceruloplasmin/Hephaestin Knockout Mice Model Morphologic and Molecular Features of AMD Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2728 - 2736. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ryan and J. T. Slevin Restless Legs Syndrome Journal of Pharmacy Practice, December 1, 2007; 20(6): 430 - 448. [Abstract] [PDF] |
||||
![]() |
B. C. Jones, J. L. Beard, J. N. Gibson, E. L. Unger, R. P. Allen, K. A. McCarthy, and C. J. Earley Systems genetic analysis of peripheral iron parameters in the mouse Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R116 - R124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C McCann and B. N Ames An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function Am. J. Clinical Nutrition, April 1, 2007; 85(4): 931 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Golub, C. E. Hogrefe, and S. L. Germann Iron Deprivation during Fetal Development Changes the Behavior of Juvenile Rhesus Monkeys J. Nutr., April 1, 2007; 137(4): 979 - 984. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beard Recent Evidence from Human and Animal Studies Regarding Iron Status and Infant Development J. Nutr., February 1, 2007; 137(2): 524S - 530S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Anderson, P. T. Cooney, and K. M. Erikson Brain Manganese Accumulation is Inversely Related to {gamma}-Amino Butyric Acid Uptake in Male and Female Rats Toxicol. Sci., January 1, 2007; 95(1): 188 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Ames Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage PNAS, November 21, 2006; 103(47): 17589 - 17594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ryan and J. T. Slevin Restless legs syndrome. Am. J. Health Syst. Pharm., September 1, 2006; 63(17): 1599 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S Golub, C. E Hogrefe, A. F Tarantal, S. L Germann, J. L Beard, M. K Georgieff, A. Calatroni, and B. Lozoff Diet-induced iron deficiency anemia and pregnancy outcome in rhesus monkeys Am. J. Clinical Nutrition, March 1, 2006; 83(3): 647 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shao, G. Xi, Y. Hua, T. Schallert, and B. Felt Intracerebral Hemorrhage in the Iron-Deficient Rat Stroke, March 1, 2005; 36(3): 660 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hahn, Y. Qian, T. Dentchev, L. Chen, J. Beard, Z. L. Harris, and J. L. Dunaief Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration PNAS, September 21, 2004; 101(38): 13850 - 13855. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Surguladze, K. M. Thompson, J. L. Beard, J. R. Connor, and M. G. Fried Interactions and Reactions of Ferritin with DNA J. Biol. Chem., April 9, 2004; 279(15): 14694 - 14702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Grant, J. A. Wiesinger, J. L. Beard, and M. T. Cantorna Iron-Deficient Mice Fail to Develop Autoimmune Encephalomyelitis J. Nutr., August 1, 2003; 133(8): 2635 - 2638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beard Iron Deficiency Alters Brain Development and Functioning J. Nutr., May 1, 2003; 133(5): 1468S - 1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beard, K. M. Erikson, and B. C. Jones Neonatal Iron Deficiency Results in Irreversible Changes in Dopamine Function in Rats J. Nutr., April 1, 2003; 133(4): 1174 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Han, J. R. Day, J. R. Connor, and J. L. Beard H and L Ferritin Subunit mRNA Expression Differs in Brains of Control and Iron-Deficient Rats J. Nutr., September 1, 2002; 132(9): 2769 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Piñero, B. C. Jones, and J. L. Beard Variations in Dietary Iron Alter Behavior in Developing Rats J. Nutr., February 1, 2001; 131(2): 311 - 318. [Abstract] [Full Text] |
||||
![]() |
J. L. Beard Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning J. Nutr., February 1, 2001; 131(2): 568S - 580. [Abstract] [Full Text] |
||||
![]() |
C. L. Kwik-Uribe, D. Gietzen, J. B. German, M. S. Golub, and C. L. Keen Chronic Marginal Iron Intakes during Early Development in Mice Result in Persistent Changes in Dopamine Metabolism and Myelin Composition J. Nutr., November 1, 2000; 130(11): 2821 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Erikson, B. C. Jones, and J. L. Beard Iron Deficiency Alters Dopamine Transporter Functioning in Rat Striatum J. Nutr., November 1, 2000; 130(11): 2831 - 2837. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Kwik-Uribe, M. S. Golub, and C. L. Keen Chronic Marginal Iron Intakes during Early Development in Mice Alter Brain Iron Concentrations and Behavior Despite Postnatal Iron Supplementation J. Nutr., August 1, 2000; 130(8): 2040 - 2048. [Abstract] [Full Text] |
||||
![]() |
B. Lozoff, E. Jimenez, J. Hagen, E. Mollen, and A. W. Wolf Poorer Behavioral and Developmental Outcome More Than 10 Years After Treatment for Iron Deficiency in Infancy Pediatrics, April 1, 2000; 105(4): 51e - 51. [Abstract] [Full Text] |
||||
![]() |
E. Pollitt Developmental Sequel from Early Nutritional Deficiencies: Conclusive and Probability Judgements J. Nutr., February 1, 2000; 130(2): 350 - 350. [Abstract] [Full Text] |
||||
< |